Products for Research Use Only
RegisterLogin

Brivekimig

CAT: 0804-HY-P990907-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P990907-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Brivekimig (F-027300252) is a bispecific nanobody against TNF and OX40L. Brivekimig exhibits immunomodulatory activity and can be used in the research of diseases such as hidradenitis suppurativa[1][2].
CAS Number
2834733-45-6
Product Name Alternative
F-027300252; SAR-442970
UNSPSC
12352203
Target
TNF Receptor
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/brivekimig.html
Purity
98
Smiles
[Brivekimig]
Molecular Weight
(66.21 kDa)
References & Citations
[1]Brivekimig. IGMT database.|[2]Veerasubramanian PK, et al. Targeting TNF/TNFR superfamilies in immune-mediated inflammatory diseases. J Exp Med. 2024 Nov 4;221 (11) :e20240806.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
T9901A-449-01Brivekimig
GTR18608285-01Brivekimig Antibody
GTR18695701-01Brivekimig Monoclonal Antibody
MBS1581231-01Research Grade Brivekimig
PX-TA2180-01Brivekimig Biosimilar - Anti-CD252; TNFA; ALB mAb - Research Grade
A137129Brivekimig Biosimilar (Monoclonal, Immunoglobulin IG single chain of 5 VH (VH-VH-VH'-VH''-VH') monomer)

Popular Products